Hold firm pressure for at least 30 seconds
This indicates that safety signals are more visible in pooled short-term RCTs, while long-term adherence and the risks of weight rebound or metabolic withdrawal post-discontinuation remain difficult to quantify reliably in existing studies
Tirzepatide is the leading choice for weight loss, demonstrating average reductions of 12-17% in body weight, offering additional benefits for blood sugar control, but raises potential safety concerns
GLP-1 and its derived peptides mediate pain relief through direct TRPV1 inhibition without affecting thermoregulation
All required injection supplies were included, plus extra sharps, alcohol wipes, and clear instructions covering injection technique, storage, and drug information
For many, cost and insurance worries have blocked the path to achieving their weight loss objectives